Allscripts Closes Previously Announced Sale of EPSi
Allscripts (NASDAQ: MDRX) has completed the sale of its subsidiary, EPSi, to Strata Decision Technology for $365 million as of October 15. EPSi specializes in providing financial decision support tools for healthcare institutions. This strategic divestiture aligns with Allscripts' objectives to optimize its healthcare information technology offerings and streamline operations.
- Completed sale of EPSi for $365 million, enhancing cash position.
- Strategic focus on core business after divestiture.
- None.
CHICAGO--(BUSINESS WIRE)--Allscripts (NASDAQ: MDRX) closed the previously announced sale of EPSi to Strata Decision Technology on October 15 for
About Allscripts
Allscripts (NASDAQ: MDRX) is a leader in healthcare information technology solutions that advance clinical, financial and operational results. Our innovative solutions connect people, places and data across an Open, Connected Community of Health™. Connectivity empowers caregivers and consumers to make better decisions, delivering better care for healthier populations. To learn more, visit www.allscripts.com, Twitter, YouTube and The Allscripts Blog.
© 2020 Allscripts Healthcare, LLC and/or its affiliates. All Rights Reserved.
Allscripts, the Allscripts logo, and other Allscripts marks are trademarks of Allscripts Healthcare, LLC and/or its affiliates. All other products are trademarks of their respective holders, all rights reserved. Reference to these products is not intended to imply affiliation with or sponsorship of Allscripts Healthcare, LLC and/or its affiliates.
